On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost

ObjectiveThe combination of high-dose cyclophosphamide (HD-Cy) (3g/m2) plus granulocyte colony-stimulating factor (G-CSF) and on-demand plerixafor (PXF) has been considered an effective mobilization regimen of patients with multiple myeloma(MM). However, the daily multi-injection regimen of G-CSF po...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Li-qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang, Bei-Hui Huang, Wai-yi Zou, Juan Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Subjects:	pegylated granulocyte colony-stimulating factor cyclophosphamide plerixafor stem cell mobilization multiple myeloma
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1306367/full